AKIGAI AS
Operating
Utvikling og kommersialisering av legemidler og medisinske
behandlingsformer, samt det som naturlig står i forbindelse med det.
Utvikling og kommersialisering av legemidler og medisinske
behandlingsformer.
Organization
- CEO
- CK
- Chairman of the board
- MG
- Years since formation
- 4 years
- since Dec 14, 2022
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 500,000
- 1 share class
- Total number of shareholders
- 4
- companies
Financials
- Total operating income 2025
- 2,570,303
- NOK
- Annual total result 2025
- -9,234,055
- NOK
- Total equity 2025
- 16,921,014
- NOK
Last update: May 5, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
CK | Managing Director/CEO | 41.92 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
MG | Chairman | 41.92 % indirectly |
CK | Board Member | 41.92 % indirectly |
SN 1966 | Board Member | 14.83 % indirectly |
GE 1962 | Board Member | - |
KH 1960 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
MG | Chairman | 41.92 % indirectly |
CK | Managing Director/CEO, Board Member | 41.92 % indirectly |
SN 1966 | Board Member | 14.83 % indirectly |
GN | - | 1.14 % indirectly |
Last update: Jan 10, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 209,580 | 41.92 % | |
| Ordinary shares | 209,580 | 41.92 % | |
| Ordinary shares | 79,840 | 15.97 % | |
| Ordinary shares | 1,000 | 0.2 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total operating income | 2,570,303 | 0 | 0 |
Annual Total Result | -9,234,055 | -6,095,129 | -5,339,095 |
Total assets | 17,968,347 | 5,381,494 | 1,932,612 |
Total liabilities | 1,047,333 | 751,723 | 1,271,706 |
Total equity | 16,921,014 | 4,629,771 | 660,905 |
P&L
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total operating income | 2,570,303 | 0 | 0 |
Total operating costs | 11,791,345 | 6,040,414 | 5,306,505 |
Operating result | -9,221,042 | -6,040,414 | -5,306,505 |
Financial income/costs | -13,013 | -54,715 | -32,590 |
Profit before tax | -9,234,055 | -6,095,129 | -5,339,095 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -9,234,055 | -6,095,129 | -5,339,095 |
Balance overview
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total fixed assets | 3,077,896 | 1,670,182 | 853,671 |
Total current assets | 14,890,451 | 3,711,312 | 1,078,941 |
Total assets | 17,968,347 | 5,381,494 | 1,932,612 |
Short term debt | 846,925 | 551,315 | 1,271,706 |
Long term debt | 0 | 200,408 | 0 |
Total liabilities | 1,047,333 | 751,723 | 1,271,706 |
Contributed capital | 16,921,014 | 4,629,771 | 6,000,000 |
Retained earnings | 0 | 0 | -5,339,095 |
Total equity | 16,921,014 | 4,629,771 | 660,905 |
Total equity and liabilities | 17,968,347 | 5,381,494 | 1,932,612 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises